Salix’s Mark McKenna will become CEO of gastroenterology and autoimmune disease company Prometheus Biosciences Inc. (San Diego, Calif.), formerly known as Precision IBD Inc. McKenna was president at Salix Pharmaceuticals Ltd., a subsidiary of Bausch...

As the smoke clears from Jiankui He’s bombshell germline editing announcement, the gap between where the gene editing field is now and where it would need to be to support responsible germline editing has become...

TECHNOLOGY: 3D models Fundus organoids derived from human pluripotent stem cells could be used to screen therapies for peptic ulcers and other gastric diseases. The organoids were generated by culturing human pluripotent stem cells in...

Researchers at Cincinnati Children’s Hospital Medical Center have developed the first human intestinal organoid model with a functioning enteric nervous system. The model not only provides a more complete picture of human gastrointestinal (GI) physiology...

The hospital granted StemCell exclusive rights to commercialize technology that allows for the generation of gastrointestinal organoids from human pluripotent stem cells. Specifically, StemCell gained IP for intestinal and stomach organoid models, plus rights to...

Genitourinary disease INDICATION: Incontinence; pain; spinal cord injury (SCI) Mouse studies suggest medial ganglionic eminence-like cell transplants could help treat incontinence and pain associated with SCI. In a mouse model of thoracic SCI, transplant of...